Search results

...ular endothelial growth factor (VEGF) receptor inhibitors and angiogenesis inhibitors  ...ular endothelial growth factor (VEGF) receptor inhibitors and angiogenesis inhibitors {{dictionary-stub}} [[Category:Dictionary of medicine]]

== Vascular Endothelial Growth Factor Receptor (VEGFR) == ...on from pre-existing vessels. Pronounced as "vas-kyu-lar en-do-thee-lee-al growth fak-tor re-sep-tor", the term is derived from the Latin words 'vasculum' me

...[[inhibitor]] that selectively inhibits the [[vascular endothelial growth factor receptor 2]] (VEGFR2), also known as KDR. It is an orally bioavailable, syn ...ating its inhibitory nature), and "ib" (a common suffix for small molecule inhibitors).

...y are commonly used in the treatment of [[cancer]] as they can prevent the growth of cancerous tumors by cutting off their blood supply. ...s that trigger angiogenesis. This includes the vascular endothelial growth factor (VEGF) and its receptor (VEGFR), which are key players in the process of an

...e of [[biological therapy]] that targets the [[vascular endothelial growth factor receptor 2]] (VEGFR-2), which plays a significant role in [[angiogenesis]]. * [[Vascular endothelial growth factor receptor 2]] (VEGFR-2): A protein that plays a critical role in angiogenesi

...ancer]]. It is a type of [[biological therapy]] that works by blocking the growth of new blood vessels, thereby starving the cancer cells of the nutrients th ...mation of new blood vessels. By blocking VEGF, Rafivirumab can prevent the growth of new blood vessels, thereby starving the cancer cells of the nutrients th

...ngiogenesis). In cancer treatment, angiogenesis inhibitors may prevent the growth of new blood vessels that tumors need to grow. ...at blocks vascular endothelial growth factor (VEGF), which may prevent the growth of new blood vessels that tumors need to grow.

...ed in the treatment of various types of cancer. It works by inhibiting the growth of new blood vessels (angiogenesis) in tumors, thereby depriving them of th ...ich are the cells that line the inside of blood vessels. This inhibits the growth of new blood vessels in tumors.

...endothelial growth factor receptor 2]] (VEGFR2), [[platelet-derived growth factor receptor]] (PDGFR), and [[Flt3]]. ...ngrui Medicine Co., Ltd.) and "tinib" (a common suffix for tyrosine kinase inhibitors).